
“Get Ready for a Game-Changing Merger: Alumis and ACELYRIN Join Forces to Revolutionize Immune-mediated Disease Treatment!”
Welcome to the Wonderful World of Clinical Trials! Exciting Updates from Alumis Pharmaceuticals Phase 3 ONWARD Trials for ESK-001 Alumis Pharmaceuticals is making waves in the medical world with their groundbreaking Phase 3 ONWARD trials for ESK-001 in moderate-to-severe plaque psoriasis. The company has recently announced that the topline data for these trials is on…